IN RE REZULIN PRODUCTS LIABILITY LITIGATION

MDL No. 1348, Master File No. 00 Civ. 2843(LAK).

361 F.Supp.2d 268 (2005)

In re REZULIN PRODUCTS LIABILITY LITIGATION. This paper relates to: 00 Civ. 7632, 01 Civ. 0049, 01 Civ. 3560, 01 Civ. 5763, 01 Civ. 5764, 01 Civ. 6053, 01 Civ. 6054, 01 Civ. 6065, 01 Civ. 6057, 01 Civ. 6058, 01 Civ. 6059, 01 Civ. 6060, 01 Civ. 6062, 01 Civ. 8159, 01 Civ. 10562, 01 Civ. 10563, 01 Civ. 10564, 01 Civ. 11878, 02 Civ. 1719, 02 Civ. 1724, 02 Civ. 9952.

United States District Court, S.D. New York.

March 15, 2005.


Attorney(s) appearing for the Case

Zoe B. Littlepage, Joshua Brockman, Houston, TX, Grace S. Elmore, Beaumont, TX, Littlepage & Associates P.C., Michael T. Gallagher, John H. Kim, The Gallagher Law Firm, Houston, TX, for Plaintiffs.

David Klingsberg, Maris Veidemanis, Bert L. Slonim, Wendy S. Dowse, Kaye Scholer LLP, New York City, for Defendants.


MEMORANDUM OPINION

KAPLAN, District Judge.

Defendants Pfizer, Inc. and its affiliates ("Pfizer") move for summary judgment dismissing the claims of nine plaintiffs whose Fact Sheet responses do not assert that they suffered any injury, or who claim there only that they fear future injury, as a result of their ingestion of Rezulin. They argue that plaintiffs who do not claim any injury cannot meet the standing requirements of Article III of the Constitution...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases